… The discovery of epidermal growth factor receptor (EGFR) mutations in never-smokers has
been … growth factor receptor exon 19 and exon 21 mutations treated with gefitinib or erlotinib. …

… ), mutations in the epidermal growth factor receptor (EGFR) … Experimental Design: In patients
with NSCLC, EGFR exon … % (43 of 70) had an EGFR exon 19 deletion. After treatment with …

… Exon 19 deletion and exon 21 L858R mutation were the most common epidermal growth
factor receptor (EGFR) mutations. We examined the clinical impact of these two mutations in …

… in exon 20 of epidermal growth factor receptor (EGFR) are limited. To increase understanding
of the influence of exon … exon 20 mutations and analyzed the gefitinib treatment response. …

… To better understand the patterns of resistance or response to EGFR TKIs of exon 20 insertion
mutations, we studied representative EGFR exon 20 mutations using in vitro systems. We …

… Deletion of exon 19 of the epidermal growth factor receptor (EGFR) and mutation of exon 21
… This study investigated the clinical impact of EGFR exon 19 deletion and L858R mutation by …

… Therapeutic targeting of epidermal growth factor receptor (EGFR) with EGFR tyrosine … In
particular, an EGFR exon 19 deletion (exon19del) and the L858R point mutation in exon 21 are …

… treatment and outcome of epidermal growth factor receptor (EGFR) exon 20-mutated lung …
profile and survival of lung cancer patients with exon 20 mutations. We compared our results …

… EGFR exon 20 insertion mutations are rare in NSCLC. There is a high unmet need in
patients with exon 20 insertions, including effective therapies. Prospective cohort studies are …

… KIT receptor and in the platelet-derived growth factor receptor-α. Following treatment with
imatinib, patients with exon … in survival compared with those with an exon 9 KIT mutation (19). …